Published September 21, 2023
| Version v1
Figure
Open
The Magee 3 Equation Predicts Favorable Pathologic Response to Neoadjuvant Endocrine Therapy in Breast Cancer Patients
Creators
- 1. Department of Clinical Oncology, Barretos Cancer Hospital, 14784-400 Barretos-SP, Brazil;
- 2. Barretos School of Health Sciences Dr. Paulo Prata – FACISB, 14785-002, Barretos-SP, Brazil;
- 3. Department of Pathology, Barretos Cancer Hospital, 14784-400, Barretos-SP, Brazil;
Description
Supplementary Figure 1: Comparison between ROC curves of ME1, ME2, ME3, and MEm scores in a sample of breast cancer patients undergoing neoadjuvant endocrine therapy.
Supplementary Figure 2: ROC curves with their respective confidence intervals and AUC values in the sample of breast cancer patients, excluding those with clinical stage IA tumors. A: ME1. B: ME2. C: ME3. D: MEm.
Supplementary Figure 3: Comparison between ROC curves of ME1, ME2, ME3, and MEm scores in the sample of breast cancer patients undergoing neoadjuvant endocrine therapy (excluding those with clinical stage IA tumors).